key: cord-0732353-noo4md1v
authors: Viguier, Alain; Delamarre, Louis; Duplantier, Julien; Olivot, Jean Marc; Bonneville, Fabrice
title: Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection
date: 2020-05-04
journal: J Neuroradiol
DOI: 10.1016/j.neurad.2020.04.003
sha: 322094fc3c44508ac08af6f3cc488dfb6b2c1abb
doc_id: 732353
cord_uid: noo4md1v

nan

microg/mL) and fibrinogen (8.2 g/L), and coagulation activation with elevated D-dimer (2220 ng/mL). Platelets were normal. Antiphospholipid antibodies were negative. EKG was in sinus rhythm. As the symptoms had been evolving for more than 9 hours and there was no proximal large vessel occlusion, we did not propose a revascularization treatment. The patient was transferred to medical ICU where high flow nasal cannula oxygen therapy and anticoagulation by subcutaneous low molecular weight heparin (enoxaparin b.i.d.) were started. His respiratory status improved, no recurrent emboli occurred and the thrombus has disappeared on follow up ultrasound examination performed 15 days after stroke onset. The patient was transferred to neurological ward on April 10th and discharged 7 days later. Neurological exam at discharge found a persistent moderate aphasia (NIHSS=3).

To the best of our knowledge, this is the first case of acute brain infarction due to common carotid artery thrombus in the course of a severe COVID-19 infection. In non COVID-19 stroke patients, intraluminal floating thrombi of the cervical arteries are rare and usually occur on ulcerated plaques or plaques with stenosis > 50% of the internal carotid artery (2) . It is even more unusual on nonatheromatous and non-dissecting processes of the cervical arteries (3). Here, this soft and smooth hypodense plaque underlying the thrombus was non-ulcerated, non-stenosing and was located on the common carotid artery. Such a location is exceptional and represents 1% of all intraluminal thrombi in the cervico-cephalic arteries responsible of stroke (2) . In a Covid-19 cohort of 226 patients, neurologic manifestations have been reported in 36 % with 5 patients experiencing acute ischemic strokes. If the origin and precise mechanism of the strokes were not described, all patients but one were in the severe infection group with elevated D-dimer and C-reactive protein, accounting for 4 % of this group (4). Three cases from another study have been associated with antiphospholipid antibodies, which were negative in our case report (5) . More generally, one of the most significant poor prognostic features in the hospitalized COVID-19 patient is the development of a coagulopathy leading, for some of them, to multiple organ dysfunctions (6) . We speculate that this large floating intraluminal thrombus, occurring at an unusual site, was primarily due to heightened thrombotic proclivity, as evidenced by significantly elevated D-dimer level, but we cannot exclude a direct role of Covid-19 infection on atheromatous plaque stability (7) .

In summary, this case illustrates that source of stroke should be sought by cervical CTA covering from the aortic arch to the vertex, without overlooking common carotid arteries and emphasized the need for COVID-19 coagulopathy management (8).

A. VIGUIER, page 5

Hematological findings and complications of COVID-19. Am J Hematol. Epub 2020 Apr 13. 

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Intraluminal Thrombi in the Cervico-Cephalic Arteries. Clinical-Imaging Manifestations, Treatment Strategies, and Outcome

Beyond plaque: A pictorial review of non-atherosclerotic abnormalities of extracranial carotid arteries

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Potential Effects of Coronaviruses on the Cardiovascular System: A Review